Perioperative Treatment of the Patient Taking Anticoagulation Medication

Oral and Maxillofacial Surgery Clinics of North America

Volumn 18, Issue 2, 2006, Pages 151-159

  Cunningham Jr , Larry L ^a   Brandt, M Todd ^a   Aldridge, Eron ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CLOPIDOGREL; GELATIN SPONGE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROTAMINE; PROTHROMBIN; TICLOPIDINE; TRANEXAMIC ACID; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG PROTEIN BINDING; ELECTIVE SURGERY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; MAXILLOFACIAL SURGERY; ORAL SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PUBLISHING; REVIEW; SURGEON; SURGICAL PATIENT; SURGICAL RISK; THROMBOCYTOPENIA; THROMBOEMBOLISM; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 33645944679     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2005.12.009     Document Type: Review

References (24)

1. Dunn A.S., and Turpie A.G. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163 8 (2003) 901-908
2. Solomon J.M., and Schow S.R. The potential risks, complications, and prevention of deep vein thrombosis in oral and maxillofacial surgery patients. J Oral Maxillofac Surg 53 12 (1995) 1441-1447
3. Wakefield T.W. Hemostasis. In: Greenfield L.J., Oldham K.T., and Mulholland M.W. (Eds). Surgery: scientific principles and practice (2001), Lippincott, Williams & Wilkins, Philadelphia 86-107
4. Scott-Conner C.E.H., Spence R.K., Shander A., et al. Hemostasis, thrombosis, hematopoiesis, and blood transfusions. In: O'Leary J.P. (Ed). The physiologic basis of surgery (2002), Lippincott, Williams & Wilkins, Philadelphia 531-547
5. Guyton A.C., and Hall J.E. Hemostasis and blood coagulation. In: Guyton A.C., and Hall J.E. (Eds). Textbook of medical physiology (2002), Philadelphia, WB Saunders 419-429
6. Andritsos L., Yusen R.D., and Eby C. Disorders of hemostasis. In: Green G.B., Harris I.S., Lin G.A., et al. (Eds). The Washington manual of medical therapeutics (2004), Lippincott, Williams & Wilkins, Philadelphia 398-422
7. Souto J.C., Oliver A., Zuazu-Jausoro I., et al. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 54 1 (1996) 27-32 [discussion 323]
8. Blinder D., Manor Y., Martinowitz U., et al. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 2 (1999) 137-140
9. Blinder D., Manor Y., Martinowitz U., et al. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 30 6 (2001) 518-521
10. Mehra P., Cottrell D.A., Bestgen S.C., et al. Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 58 2 (2000) 198-202
11. Sear J.W., and Higham H. Issues in the perioperative management of the elderly patient with cardiovascular disease. Drugs Aging 19 6 (2002) 429-451
12. Phan T.G., Koh M., and Wijdicks E.F. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 57 12 (2000) 1710-1713
13. Ananthasubramaniam K., Beattie J.N., Rosman H.S., et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?. Chest 119 2 (2001) 478-484
14. Larson B.J., Zumberg M.S., and Kitchens C.S. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 127 3 (2005) 922-927
15. Kapetanakis E.I., Medlam D.A., Boyce S.W., et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?. Eur Heart J 26 6 (2005) 576-583
16. Robless P., Mikhailidis D.P., and Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 88 6 (2001) 787-800
17. Yende S., and Wunderink R.G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29 12 (2001) 2271-2275
18. Sharma A.K., Ajani A.E., Hamwi S.M., et al. Major noncardiac surgery following coronary stenting: when is it safe to operate?. Catheter Cardiovasc Interv 63 2 (2004) 141-145
19. Payne D.A., Hayes P.D., Jones C.I., et al. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 35 6 (2002) 1204-1209
20. Smout J., and Stansby G. Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons. Ann R Coll Surg Engl 85 2 (2003) 97-101
21. Harder S., Klinkhardt U., and Alvarez J.M. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 43 14 (2004) 963-981
22. Johnson Leong C., and Rada R.E. The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy. J Am Dent Assoc 133 8 (2002) 1083-1087
23. Spandorfer J.M., Lynch S., Weitz H.H., et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84(4):478-80, A10
24. Tinmouth A.H., Morrow B.H., Cruickshank M.K., et al. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 35 6 (2001) 669-674